BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 11 filers reported holding BIO BLAST PHARMA LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 250,970 | $402,000 | 0.13% |
| SABBY MANAGEMENT, LLC | 830,253 | $1,328,000 | 0.07% |
| Visium Asset Management, LP | 50,833 | $81,000 | 0.01% |
| WEDBUSH SECURITIES INC | 17,000 | $27,000 | 0.00% |
| OPPENHEIMER & CO INC | 51,600 | $82,000 | 0.00% |
| Acrospire Investment Management LLC | 1,000 | $2,000 | 0.00% |
| HighTower Advisors, LLC | 35,700 | $57,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,255 | $2,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,000 | $2,000 | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 300 | $0 | 0.00% |